Not yet recruiting
Pancreatic carcinoma
Not yet recruitingInvestigationalNo placebo
Phase II/III trial of autologous dendritic cells loaded with allogenic mesothelioma lysate in patients with borderline resectable pancreatic cancer
InvestigationalNo placebo
- Substances:AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES











